Behavioral manifestation; Checklist; Democratic Republic of Congo; Dysmorphism; Fragile X syndrome
Abstract :
[en] Screening for fragile X syndrome (FXS) is essential in children with developmental delay or intellectual disability (ID). In addition, using clinical screening checklists remains of high interest in resource-limited settings. We aimed to gain insight into the prevalence of FXS and the distribution of CGG alleles and to evaluate the usefulness of three checklists in specialized institutions in Kinshasa, DR Congo. We recruited 80 males and 25 females from six specialized institutions in Kinshasa and administered a questionnaire comprising items from the following FXS checklists: Hagerman, Maes, and Guruju. FMR1 CGG repeats were assessed for every patient. About 37% of patients were referable for FX testing based on Hagerman's checklist, 35% for Maes', and 43.80% for Guruju's, but none of them was molecularly confirmed to have FXS. Thus, specificities were 62.86, 64.76, and 56.5%, respectively, for Hagerman, Maes, and Guruju, respectively. The mean CGG allele size was 28.55 +/- 2.83 (ranges, 17-48). The 29 CGG was the most frequent allele (24.61%). Thus, existing checklists should not be automatically applied to Congolese patients without adjustments. The distribution of CGG repeats and the number of CGG alleles are similar to other African studies.
Behery, A.K., Fragile x-syndrome: clinical and molecular studies (2008) J Egypt Public Health Assoc, 83, pp. 273-283
Butler, M.G., Mangrum, T., Gupta, R., Singh, D.N., A 15-item checklist for screening mentally retarded males for the fragile X syndrome (1991) Clin Genet, 39, pp. 347-354
Chiurazzi, P., Destro-Bisol, G., Genuardi, M., Oostra, B.A., Spedini, G., Neri, G., Extended gene diversity at the FMR1 locus and neighbouring CA repeats in a sub-Saharan population (1996) Am J Med Genet, 64, pp. 216-219
Crawford, D.C., Zhang, F., Wilson, B., Warren, S.T., Sherman, S.L., Fragile X CGG repeat structures among African-Americans: identification of a novel factor responsible for repeat instability (2000) Hum Mol Genet, 9, pp. 1759-1769
Crawford, D.C., Acuna, J.M., Sherman, S.L., FMR1 and the fragile X syndrome: human genome epidemiology review (2001) Genet Med, 3, pp. 359-371. , https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493892/
Crawford, D.C., Prevalence of the fragile X syndrome in African-Americans (2002) Am J Med Genet, 110, pp. 226-233
D’Hulst, C., Kooy, R.F., Fragile X syndrome: from molecular genetics to therapy (2009) J Med Genet, 46, pp. 577-584
de Vries, B.B., Screening for the fragile X syndrome among the mentally retarded: a clinical study. The Collaborative Fragile X Study Group (1999) J Med Genet, 36, pp. 467-470
Eichler, E.E., Nelson, D.L., Genetic variation and evolutionary stability of the FMR1 CGG repeat in six closed human populations (1996) Am J Med Genet, 64, pp. 220-225
Eichler, E.E., Hammond, H.A., Macpherson, J.N., Ward, P.A., Nelson, D.L., Population survey of the human FMR1 CGG repeat substructure suggests biased polarity for the loss of AGG interruptions (1995) Hum Mol Genet, 4, pp. 2199-2208
Essop, F.B., Krause, A., Diagnostic, carrier and prenatal genetic testing for fragile X syndrome and other FMR-1-related disorders in Johannesburg, South Africa: a 20-year review (2013) S Afr Med J, 103, pp. 994-998
Gabis, L., Kesner, Y., Behavioral characteristics of children with fragile X syndrome (2007) Harefuah, 146, pp. 469-474. , 499
Goldman, A., Jenkins, T., Krause, A., Molecular evidence that fragile X syndrome occurs in the South African black population (1998) J Med Genet, 35, p. 878
Guruju, M.R., Assessment of a clinical checklist in the diagnosis of fragile X syndrome in India (2009) J Clin Neurosci, 16, pp. 1305-1310
Hagerman, R.J., Lessons from fragile X regarding neurobiology, autism, and neurodegeneration (2006) J Dev Behav Pediatr, 27, pp. 63-74
Hagerman, R.J., Amiri, K., Cronister, A., Fragile X checklist (1991) Am J Med Genet, 38, pp. 283-287
Kunst, C.B., Zerylnick, C., Karickhoff, L., Eichler, E., Bullard, J., Chalifoux, M., Holden, J.J., Warren, S.T., FMR1 in global populations (1996) Am J Hum Genet, 58, pp. 513-522
Lachiewicz, A.M., Dawson, D.V., Spiridigliozzi, G.A., Physical characteristics of young boys with fragile X syndrome: reasons for difficulties in making a diagnosis in young males (2000) Am J Med Genet, 92, pp. 229-236
Laing, S., Partington, M., Robinson, H., Turner, G., Clinical screening score for the fragile X (Martin-Bell) syndrome (1991) Am J Med Genet, 38, pp. 256-259
Lozano, R., Rosero, C.A., Hagerman, R.J., Fragile X spectrum disorders (2014) Intractable Rare Dis Res, 3, pp. 134-146
Lubala, T.K., Fragile X syndrome with mosaic size mutation in a Bantu patient from Central Africa (2018) Clin Dysmorphol, , https://doi.org/10.1097/MCD.0000000000000208
Maddalena, A., Technical standards and guidelines for fragile X: the first of a series of disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics. Quality Assurance Subcommittee of the Laboratory Practice Committee (2001) Genet Med, 3, pp. 200-205
Maes, B., Fryns, J.P., Ghesquiere, P., Borghgraef, M., Phenotypic checklist to screen for fragile X syndrome in people with mental retardation (2000) Ment Retard, 38, pp. 207-215
McDonald-McGinn, D.M., The 22q11.2 deletion in African-American patients: an underdiagnosed population? (2005) Am J Med Genet A, 134, pp. 242-246
Miller, S.A., Dykes, D.D., Polesky, H.F., A simple salting out procedure for extracting DNA from human nucleated cells (1988) Nucleic Acids Res, 16, p. 1215
Mirkin, S.M., Expandable DNA repeats and human disease (2007) Nature, 447, pp. 932-940
Moeschler, J.B., Shevell, M., Comprehensive evaluation of the child with intellectual disability or global developmental delays (2014) Pediatrics, 134, pp. e903-e918
Monaghan, K.G., Lyon, E., Spector, E.B., ACMG Standards and Guidelines for fragile X testing: a revision to the disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics and Genomics (2013) Genet Med, 15, pp. 575-586
Oostra, B.A., Willemsen, R., FMR1: a gene with three faces (2009) Biochim Biophys Acta, 1790, pp. 467-477
Peprah, E.K., Allen, E.G., Williams, S.M., Woodard, L.M., Sherman, S.L., Genetic diversity of the fragile X syndrome gene (FMR1) in a large sub-Saharan West African population (2010) Ann Hum Genet, 74, pp. 316-325
Schwartz, C.E., Fragile X syndrome: incidence, clinical and cytogenetic findings in the black and white populations of South Carolina (1988) Am J Med Genet, 30, pp. 641-654
Sullivan, K., Hatton, D., Hammer, J., Sideris, J., Hooper, S., Ornstein, P., Bailey, D., Jr., ADHD symptoms in children with FXS (2006) Am J Med Genet A, 140, pp. 2275-2288
Tuncbilek, E., Alikasifoglu, M., Boduroglu, K., Aktas, D., Anar, B., Frequency of fragile X syndrome among Turkish patients with mental retardation of unknown etiology (1999) Am J Med Genet, 84, pp. 202-203
Turner, G., Webb, T., Wake, S., Robinson, H., Prevalence of fragile X syndrome (1996) Am J Med Genet, 64, pp. 196-197
Tzeng, C.C., Cho, W.C., Kuo, P.L., Chen, R.M., Pilot fragile X screening in normal population of Taiwan (1999) Diagn Mol Pathol, 8, pp. 152-156
Van Esch, H., The fragile X premutation: new insights and clinical consequences (2006) Eur J Med Genet, 49, pp. 1-8
Yim, S.Y., Jeon, B.H., Yang, J.A., Kim, H.J., Fragile X syndrome in Korea: a case series and a review of the literature (2008) J Korean Med Sci, 23, pp. 470-476
